Health care biotech companies by today's price change
How far the share price has moved since the previous close.
CG Oncology leads the 24 health care biotech companies ranked by today's price change, at +3.01%, ahead of Scholar Rock Holding (+2.62%) and Repligen (+2.38%). Figures as of 19 Nov 2026, 15:40 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 24
- First
- CG Oncology+3.01%
- Median
- -0.58%
- Combined market value
- AED 3.04T
- Countries
- 5
Market values as of .
All countries▾
Health Care▾
Biotech▾
| # | Company | Today ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | CG OncologyCGON · Health Care | +3.01% | AED 27B | AED 302.66 | 3.01% up | 97% up | ||
| 2 | Scholar Rock HoldingSRRK · Health Care | +2.62% | AED 22.1B | AED 180.91 | 2.62% up | 26% up | ||
| 3 | RepligenRGEN · Health Care | +2.38% | AED 41.5B | AED 649.22 | 2.38% up | 12% up | ||
| 4 | Revolution MedicinesRVMD · Health Care | +2.06% | AED 129.6B | AED 599.07 | 2.06% up | 129% up | ||
| 5 | Twist BioscienceTWST · Health Care | +1.41% | AED 29.5B | AED 433.35 | 1.41% up | 346% up | ||
| 6 | VaxcytePCVX · Health Care | +1.26% | AED 34.5B | AED 217.64 | 1.26% up | 23% up | ||
| 7 | Adaptive BiotechnologiesADPT · Health Care | +1.23% | AED 17.1B | AED 105.81 | 1.23% up | 74% up | ||
| 8 | CRISPR TherapeuticsCRSP · Health Care | +0.40% | AED 14.4B | AED 148.19 | 0.40% up | 18% down | ||
| 9 | QiagenQGEN · Health Care | +0.20% | AED 37.7B | AED 182.38 | 0.20% up | 9% up | ||
| 10 | Bio-TechneTECH · Health Care | -0.04% | AED 42B | AED 267.08 | 0.04% down | 24% up | ||
| 11 | Krystal BiotechKRYS · Health Care | -0.25% | AED 34.2B | AED 1,155.20 | 0.25% down | 54% up | ||
| 12 | argenxARGX · Health Care | -0.36% | AED 216.6B | AED 3,444.35 | 0.36% down | 2% up | ||
| 13 | Kodiak SciencesKOD · Health Care | -0.81% | AED 23.3B | AED 356.32 | 0.81% down | 399% up | ||
| 14 | BioNTechBNTX · Health Care | -1.06% | AED 75B | AED 302.53 | 1.06% down | 14% down | ||
| 15 | AmgenAMGN · Health Care | -1.15% | AED 871.7B | AED 1,611.54 | 1.15% down | 32% up | ||
| 16 | ImmunovantIMVT · Health Care | -1.18% | AED 24.9B | AED 120.39 | 1.18% down | 46% up | ||
| 17 | BiogenBIIB · Health Care | -1.29% | AED 134.7B | AED 911.43 | 1.29% down | 49% up | ||
| 18 | ModernaMRNA · Health Care | -1.35% | AED 288.5B | AED 712.94 | 1.35% down | 780% up | ||
| 19 | Kymera TherapeuticsKYMR · Health Care | -1.37% | AED 37.5B | AED 438.77 | 1.37% down | 87% up | ||
| 20 | Gilead SciencesGILD · Health Care | -1.70% | AED 756.6B | AED 610.02 | 1.70% down | 35% up | ||
| 21 | Neurocrine BiosciencesNBIX · Health Care | -2.30% | AED 59.1B | AED 584.35 | 2.30% down | 17% up | ||
| 22 | ImmunityBioIBRX · Health Care | -2.84% | AED 25.4B | AED 23.91 | 2.84% down | 232% up | ||
| 23 | ExelixisEXEL · Health Care | -3.56% | AED 59B | AED 241.88 | 3.56% down | 63% up | ||
| 24 | Halozyme TherapeuticsHALO · Health Care | -3.82% | AED 38.6B | AED 338.39 | 3.82% down | 39% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 3.6726 AED).
Questions and answers
Which health care biotech companies rank first by today's price change?
CG Oncology (+3.01%), Scholar Rock Holding (+2.62%) and Repligen (+2.38%) are the top three of the 24 health care biotech companies ranked by today's price change as of 19 Nov 2026, 15:40 UTC.
How many health care biotech companies are in this ranking?
24 are ranked by today's price change.
What are these health care biotech companies worth together?
The 24 health care biotech companies ranked by today's price change have a combined market value of AED 3.04T as of 19 Nov 2026, 15:40 UTC.
What does ranking by today's price change measure?
How far the share price has moved since the previous close.
Learn how this ranking works
All markets guides →- 52-week high and low: what the range tells you
A stock's 52-week high and low are the highest and lowest prices it reached over the past year. Where today's price sits in that range, from 0% at the low to 100% at the high, shows how the past year has gone. Sources differ on whether they use closing or intraday prices, so the same stock's range can differ slightly.
- Drawdown and recovery: why a 50% fall needs a 100% gain
A drawdown is how far a price has fallen from its previous peak, as a percentage of that peak. Recovery needs a larger gain than the fall, because the gain starts from a smaller base: a 20% drop needs a 25% rise to get back, a 50% drop needs 100%, and a 75% drop needs 300%.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Health care biotech companies by today's price change”, data as of 19 November 2026. https://funkfolio.com/companies/category/biotech?sector=health-care&by=day-change
Underlying data: Yahoo Finance; SEC EDGAR.